Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1998 1
1999 1
2000 1
2001 3
2002 62
2003 68
2004 81
2005 86
2006 77
2007 114
2008 152
2009 159
2010 183
2011 199
2012 194
2013 204
2014 231
2015 260
2016 247
2017 210
2018 209
2019 236
2020 268
2021 247
2022 241
2023 262
2024 77

Text availability

Article attribute

Article type

Publication date

Search Results

3,529 results

Results by year

Filters applied: . Clear all
Page 1
Immunomodulatory functional foods and their molecular mechanisms.
Kim JH, Kim DH, Jo S, Cho MJ, Cho YR, Lee YJ, Byun S. Kim JH, et al. Among authors: lee yj. Exp Mol Med. 2022 Jan;54(1):1-11. doi: 10.1038/s12276-022-00724-0. Epub 2022 Jan 25. Exp Mol Med. 2022. PMID: 35079119 Free PMC article. Review.
Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy.
Uribe-Herranz M, Beghi S, Ruella M, Parvathaneni K, Salaris S, Kostopoulos N, George SS, Pierini S, Krimitza E, Costabile F, Ghilardi G, Amelsberg KV, Lee YG, Pajarillo R, Markmann C, McGettigan-Croce B, Agarwal D, Frey N, Lacey SF, Scholler J, Gabunia K, Wu G, Chong E, Porter DL, June CH, Schuster SJ, Bhoj V, Facciabene A. Uribe-Herranz M, et al. Among authors: lee yg. Mol Ther. 2023 Mar 1;31(3):686-700. doi: 10.1016/j.ymthe.2023.01.012. Epub 2023 Jan 14. Mol Ther. 2023. PMID: 36641624 Free PMC article.
Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma.
Chuah S, Lee J, Song Y, Kim HD, Wasser M, Kaya NA, Bang K, Lee YJ, Jeon SH, Suthen S, A'Azman S, Gien G, Lim CJ, Chua C, Hazirah SN, Lee HK, Lim JQ, Lim TKH, Yeong J, Chen J, Shin EC, Albani S, Zhai W, Yoo C, Liu H, Choo SP, Tai D, Chew V. Chuah S, et al. Among authors: lee yj. J Hepatol. 2022 Sep;77(3):683-694. doi: 10.1016/j.jhep.2022.03.039. Epub 2022 Apr 15. J Hepatol. 2022. PMID: 35430299 Free article.
KAAACI Guidelines for Allergen Immunotherapy.
Lee HY, Lee SM, Kang SY, Kim K, Kim JH, Ryu G, Min JY, Park KH, Park SY, Sung M, Lee Y, Yang EA, Jee HM, Ha EK, Shin YS, Chung EH, Choi SH, Koh YI, Kim ST, Nahm DH, Park JW, Shim JY, An YM, Han DH, Han MY, Lee YW, Choi JH; Korean Academy of Asthma Allergy and Clinical Immunology (KAAACI) Allergen Immunotherapy and Allergen Working Group. Lee HY, et al. Among authors: lee yw. Allergy Asthma Immunol Res. 2023 Nov;15(6):725-756. doi: 10.4168/aair.2023.15.6.725. Allergy Asthma Immunol Res. 2023. PMID: 37957792 Free PMC article. Review.
Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis.
Lee KN, Lee OY, Chun HJ, Kim JI, Kim SK, Lee SW, Park KS, Lee KL, Choi SC, Jang JY, Kim GH, Sung IK, Park MI, Kwon JG, Kim N, Kim JJ, Lee ST, Kim HS, Kim KB, Lee YC, Choi MG, Lee JS, Jung HY, Lee KJ, Kim JH, Chung H. Lee KN, et al. Among authors: lee yc. World J Gastroenterol. 2022 Nov 28;28(44):6294-6309. doi: 10.3748/wjg.v28.i44.6294. World J Gastroenterol. 2022. PMID: 36504556 Free PMC article. Clinical Trial.
Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of Helicobacter pylori Infection: A Randomized, Double-Blind, Phase III, Clinical Trial.
Choi YJ, Lee YC, Kim JM, Kim JI, Moon JS, Lim YJ, Baik GH, Son BK, Lee HL, Kim KO, Kim N, Ko KH, Jung HK, Shim KN, Chun HJ, Kim BW, Lee H, Kim JH, Chung H, Kim SG, Jang JY. Choi YJ, et al. Among authors: lee yc. Gut Liver. 2022 Jul 15;16(4):535-546. doi: 10.5009/gnl220055. Epub 2022 Jul 6. Gut Liver. 2022. PMID: 35791797 Free PMC article. Clinical Trial.
Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer.
Lee YG, Guruprasad P, Ghilardi G, Pajarillo R, Sauter CT, Patel R, Ballard HJ, Hong SJ, Chun I, Yang N, Amelsberg KV, Cummins KD, Svoboda J, Gill S, Chong EA, North K, Church SE, Fraietta JA, Chang WJ, Lacey SF, Lu XM, Zhang Y, Whig K, Schultz DC, Cherry S, Gerson J, Schuster SJ, Porazzi P, Ruella M. Lee YG, et al. Cancer Discov. 2022 Oct 5;12(10):2372-2391. doi: 10.1158/2159-8290.CD-21-1026. Cancer Discov. 2022. PMID: 35904479 Free PMC article.
Apoptosis: a Janus bifrons in T-cell immunotherapy.
Lee YG, Yang N, Chun I, Porazzi P, Carturan A, Paruzzo L, Sauter CT, Guruprasad P, Pajarillo R, Ruella M. Lee YG, et al. J Immunother Cancer. 2023 Apr;11(4):e005967. doi: 10.1136/jitc-2022-005967. J Immunother Cancer. 2023. PMID: 37055217 Free PMC article. Review.
KAAACI Allergic Rhinitis Guidelines: Part 2. Update in Non-pharmacological Management.
Park DY, Lee YJ, Kim DK, Kim SW, Yang HJ, Kim DH, Jun YJ, Park SC, Kim BS, Yang SI, Lee IH, Kim M, Ryu G, Kang SY, Kim MA, Lee SM, Kim HJ, Choi GS, Chung SJ, Lee HJ, Kim HB, Choi JH. Park DY, et al. Among authors: lee yj. Allergy Asthma Immunol Res. 2023 Mar;15(2):145-159. doi: 10.4168/aair.2023.15.2.145. Allergy Asthma Immunol Res. 2023. PMID: 37021502 Free PMC article. Review.
Editorial: Small non-coding RNAs in diseases.
Zhang K, Lee YS, Lee I, Bao X. Zhang K, et al. Among authors: lee ys. Front Mol Biosci. 2023 Jan 4;9:1086768. doi: 10.3389/fmolb.2022.1086768. eCollection 2022. Front Mol Biosci. 2023. PMID: 36660424 Free PMC article. No abstract available.
3,529 results